首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

2149704

生物製造和合成生物學市場預測至2034年—按技術平台、產品類型、生物系統、應用、最終用戶和地區分類的全球分析

Biomanufacturing & Synthetic Biology Market Forecasts to 2034 - Global Analysis By Technology Platforms, Product Types, Biological Systems, Applications, End Users and By Geography

出版日期: 2026年10月14日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計到 2026 年，全球生物製造和合成生物學市場規模將達到 155 億美元，並在預測期內以 14.3% 的複合年成長率成長，到 2034 年將達到 452 億美元。

生物製造和合成生物學是將工程原理應用於生物系統，以設計、建造和最佳化生物體，從而生產高價值材料、化學品和藥物的領域。這些技術涉及對細胞機制（例如細菌、酵母和哺乳動物細胞的機制）進行重編程，以高精度和高效率合成目標化合物。這些技術包括精準發酵、代謝工程和人工智慧驅動的生物設計。這些技術的應用確保了生質燃料、替代蛋白和藥物的永續生產，從而減少全球對傳統石油化學製程的依賴。

對永續和生物基替代品的需求日益成長

對永續生物基替代品日益成長的需求正迫使製造商採用生物製造和合成生物學解決方案，以提供先進的生產方法。人們對石油化學產品環境影響的認知不斷提高，正在加速將這些生物系統整合到生產流程中。代謝工程的進步提高了細胞產量和效率，為此轉變提供了支持。因此，企業正在投資合成生物學技術，以在遵守永續性標準的同時最佳化整體生產成本。

複雜的監管流程與規模化挑戰

先進生物製造和合成生物學製程規模化生產的高昂成本是其商業性化應用的一大障礙。從實驗室規模的發酵過渡到工業規模的生物反應器通常需要複雜的程式工程和專業的技術知識，從而大幅增加整體實施成本。此外，生物系統的變異性也限制了標準化生產模式的可預測性。這些因素共同限制了市場擴張，尤其對於技術預算有限的中小型企業而言更是如此。

替代蛋白質和生質燃料的擴張

在替代蛋白和生質燃料領域，消費者對永續消費品日益成長的需求，為生物製造和合成生物學供應商創造了巨大的成長機會。先進的生物平台以微發酵為主要原料來源，無需佔用大量土地即可高效生產高價值化合物。隨著全球對綠色技術投資的不斷成長，先進合成生物學解決方案的應用預計將顯著增加。

來自傳統石油化學生產的競爭

對傳統石油化工生產流程的持續依賴對生物製造和合成生物學市場構成重大威脅。傳統化學合成通常具有更優異的擴充性，並且對於大規模生產通用級材料的工廠更具成本效益。此外，基礎化學加工工具的快速發展正在提高傳統製造方法的效率。這種競爭壓力可能會阻礙其在非專業化應用領域的市場滲透。

新型冠狀病毒（COVID-19）的影響：

疫情初期，供應鏈受阻阻礙了生物製造技術的應用，並延緩了臨床試驗。然而，隨後對疫苗和治療藥物快速生產的需求加速了合成生物學解決方案的採用，以確保業務永續營運。疫情後，對供應鏈敏捷性和營運效率的重視加強了對生物製造技術的長期投資，推動了全球各行業市場的強勁復甦和擴張。

在預測期內，精準發酵領域預計將佔據最大的市場佔有率。

由於其無與倫比的生產效率和在各種生物製造環境中的廣泛適用性，預計微發酵技術將在預測期內佔據最大的市場佔有率。微發酵技術能夠提供卓越的細胞產量，即使在複雜的生物條件下也能有效發揮作用，從而顯著縮短生產時間並最大限度地減少常規生產過程中的資源消耗。隨著各產業越來越重視可擴展且經濟高效的生物基生產方法，對專業微發酵技術的需求持續激增，鞏固了該領域在市場上的主導地位。

預計在預測期內，人工智慧驅動的生物設計領域將呈現最高的複合年成長率。

在預測期內，人工智慧驅動的生物設計領域預計將呈現最高的成長率，這主要得益於機器學習和基因測序技術的快速發展。這些技術能夠精準最佳化細胞內代謝途徑，從而生產出高度專業化且穩健的生物製品，以滿足特定工業應用的需求。透過先進的人工智慧技術，提高產量、營運規模和代謝效率，將顯著提升製程經濟性，並加速全球商業性應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其成熟的生物技術產業和先進的研究基礎設施，這些設施廣泛應用生物製造和合成生物學技術。該地區受益於大量的研發投入、健全的智慧財產權保護以及政府對永續製造和創新的支持。此外，美國和加拿大主要產業參與者對先進合成生物學技術的早期應用，進一步鞏固了該地區的全球主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於新興經濟體快速的工業化進程和生技產業的擴張。中國、印度和日本等國正在加大對生物製造基礎設施和先進自動化技術的投資，以滿足不斷成長的國內生產需求和永續性嚴格的永續發展法規。此外，有利的政府政策、不斷成長的外國直接投資以及經濟高效的技術資源的可用性，正在加速合成生物學在全部區域的應用。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 根據客戶的興趣，我們將提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Novonesis A/S
DSM-Firmenich AG
Lonza Group AG
Thermo Fisher Scientific Inc.
Danaher Corporation
Merck KGaA
Sartorius AG
Evonik Industries AG
BASF SE
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Ginkgo Bioworks Holdings, Inc.
Twist Bioscience Corporation
Codexis, Inc.
Illumina, Inc.
LanzaTech Global, Inc.
GenScript Biotech Corporation
Recursion Pharmaceuticals, Inc.

簡介目錄圖表

Product Code: SMRC40125

According to Stratistics MRC, the Global Biomanufacturing & Synthetic Biology Market is accounted for $15.5 billion in 2026 and is expected to reach $45.2 billion by 2034 growing at a CAGR of 14.3% during the forecast period. Biomanufacturing and synthetic biology involve the application of engineering principles to biological systems to design, construct, and optimize living organisms for the production of valuable materials, chemicals, and therapeutics. They function by reprogramming cellular machinery, such as bacteria, yeast, or mammalian cells, to synthesize target compounds with high precision and efficiency. These technologies encompass precision fermentation, metabolic engineering, and AI-driven biological design. Their application ensures sustainable production of biofuels, alternative proteins, and pharmaceuticals, reducing reliance on traditional petrochemical processes globally.

Market Dynamics:

Driver:

Rising Demand for Sustainable and Bio-Based Alternatives

The escalating demand for sustainable and bio-based alternatives compels manufacturers to adopt biomanufacturing and synthetic biology solutions offering advanced production alternatives. Growing recognition of petrochemical environmental impacts is accelerating the integration of these biological systems into manufacturing frameworks. This transition is supported by advancements in metabolic engineering, which enhance cellular yield and efficiency. Consequently, enterprises are investing in synthetic biology technologies to achieve compliance with sustainability benchmarks while optimizing overall production costs.

Restraint:

Complex Regulatory Pathways and Scale-Up Challenges

The substantial expenses associated with scaling up advanced biomanufacturing and synthetic biology processes represent a significant barrier to widespread commercial adoption. Transitioning from laboratory-scale fermentation to industrial-scale bioreactors often requires complex process engineering and specialized technical expertise, which escalate overall implementation costs. Furthermore, the variability in biological systems limits the operational predictability of standardized production models. These factors collectively constrain market expansion, particularly for smaller enterprises with limited technology budgets.

Opportunity:

Expansion in Alternative Proteins and Biofuels

The alternative proteins and biofuels sectors present substantial growth opportunities for biomanufacturing and synthetic biology providers due to increasing demand for sustainable consumer goods. Advanced biological platforms offer a highly effective pathway to produce high-value compounds without extensive land use, utilizing precision fermentation as primary inputs. As global investments in green technology expand, the adoption of advanced synthetic biology solutions is expected to surge significantly.

Threat:

Competition from Traditional Petrochemical Manufacturing

The continuous reliance on traditional petrochemical manufacturing processes poses a considerable threat to the biomanufacturing and synthetic biology market. Conventional chemical synthesis often exhibits superior scalability and can be more cost-effective for facilities producing high-volume, commodity-grade materials. Additionally, the rapid advancement of basic chemical processing tools is enhancing the efficiency of conventional manufacturing methods. This competitive pressure may hinder market penetration in less specialized applications.

Covid-19 Impact:

The pandemic initially disrupted biomanufacturing deployments and delayed clinical trials due to supply chain constraints. However, the subsequent need for rapid vaccine and therapeutic production accelerated the adoption of synthetic biology solutions for resilient operations. Post-pandemic, the heightened focus on supply chain agility and operational efficiency has reinforced long-term investments in biomanufacturing technologies, driving robust market recovery and expansion across diverse industrial sectors globally.

The precision fermentation segment is expected to be the largest during the forecast period

The precision fermentation segment is expected to account for the largest market share during the forecast period, due to its unparalleled production efficiency and widespread applicability across diverse biomanufacturing environments. Precision fermentation offers exceptional cellular yield and operates effectively in complex biological conditions, which significantly reduces production time and minimizes resource consumption in daily manufacturing processes. As industries increasingly prioritize scalable and cost-effective bio-based production methods, the demand for specialized precision fermentation technologies continues to surge, thereby solidifying their dominant market position.

The AI-driven biological design segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-driven biological design segment is predicted to witness the highest growth rate, driven by rapid advancements in machine learning and genomic sequencing techniques. These technologies enable the precise optimization of cellular pathways to produce highly specialized and robust biological outputs tailored for specific industrial applications. The ability to enhance production yield, operational scalability, and metabolic efficiency through advanced AI integration significantly improves process economics, accelerating commercial adoption globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the presence of well-established biotechnology sectors and advanced research infrastructure that heavily utilize biomanufacturing and synthetic biology. The region benefits from substantial research and development investments, robust intellectual property protection, and supportive government initiatives promoting sustainable manufacturing and technological innovation. Furthermore, the early adoption of advanced synthetic biology technologies by key industry players in the United States and Canada reinforces the region's dominant position globally.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapid industrialization and expanding biotechnology sectors in emerging economies. Countries such as China, India, and Japan are increasingly investing in biomanufacturing infrastructure and advanced automation technologies to meet growing domestic production demands and stringent sustainability regulations. Additionally, favorable government policies, rising foreign direct investment, and the availability of cost-effective technological resources are collectively driving the accelerated adoption of synthetic biology across the region.

Key players in the market

Some of the key players in Biomanufacturing & Synthetic Biology Market include Novonesis A/S, DSM-Firmenich AG, Lonza Group AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sartorius AG, Evonik Industries AG, BASF SE, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Ginkgo Bioworks Holdings, Inc., Twist Bioscience Corporation, Codexis, Inc., Illumina, Inc., LanzaTech Global, Inc., GenScript Biotech Corporation, and Recursion Pharmaceuticals, Inc.

Key Developments:

In September 2026, Novonesis A/S launched a next-generation precision fermentation platform optimized for bio-based chemical production, achieving a thirty percent improvement in cellular yield while significantly reducing resource consumption requirements for global biomanufacturing operators.

In August 2026, DSM-Firmenich AG expanded its synthetic biology capacity through a strategic partnership with a leading genomics firm, enabling the scalable deployment of novel metabolic engineering modules for sustainable ingredient production.

In July 2026, Ginkgo Bioworks Holdings, Inc. secured a major supply agreement to provide customized biological design services for a prominent pharmaceutical company, facilitating the efficient integration of advanced synthetic biology tools into next-generation therapeutic ecosystems globally.

Technology Platforms Covered:

Precision Fermentation
Cell-Based Biomanufacturing
Cell-Free Biomanufacturing
Metabolic Engineering
Protein Engineering
Genome Engineering
AI-Driven Biological Design
Enzyme Engineering

Product Types Covered:

Biopharmaceuticals
Industrial Enzymes
Biofuels
Biochemicals
Bioplastics and Biomaterials
Alternative Proteins
Agricultural Biologicals

Biological Systems Covered:

Bacteria
Yeast
Fungi
Mammalian Cells
Plant Cells
Cell-Free Systems
Engineered Microbial Consortia

Applications Covered:

Pharmaceutical Manufacturing
Industrial Enzyme Production
Food and Alternative Protein Production
Biofuel Production
Biochemical Manufacturing
Bioplastics Manufacturing
Agricultural Biotechnology
Environmental Biotechnology

End Users Covered:

Pharmaceutical and Biotechnology Companies
Contract Development and Manufacturing Organizations (CDMOs)
Food and Beverage Companies
Chemical Companies
Industrial Biotechnology Companies
Agricultural Biotechnology Companies
Research Institutions
Consumer Products Companies

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Biomanufacturing & Synthetic Biology Market, By Technology Platform

5.1 Precision Fermentation
- 5.1.1 Microbial Fermentation
- 5.1.2 Yeast-Based Fermentation
- 5.1.3 Bacterial Fermentation
- 5.1.4 Fungal Fermentation
5.2 Cell-Based Biomanufacturing
- 5.2.1 Mammalian Cell Culture
- 5.2.2 Microbial Cell Culture
- 5.2.3 Plant Cell Culture
5.3 Cell-Free Biomanufacturing
5.4 Metabolic Engineering
5.5 Protein Engineering
5.6 Genome Engineering
5.7 AI-Driven Biological Design
5.8 Enzyme Engineering

6 Global Biomanufacturing & Synthetic Biology Market, By Product Type

6.1 Biopharmaceuticals
- 6.1.1 Monoclonal Antibodies
- 6.1.2 Recombinant Proteins
- 6.1.3 Vaccines
- 6.1.4 Cell and Gene Therapies
6.2 Industrial Enzymes
6.3 Biofuels
- 6.3.1 Bioethanol
- 6.3.2 Biodiesel
- 6.3.3 Sustainable Aviation Fuel
6.4 Biochemicals
6.5 Bioplastics and Biomaterials
6.6 Alternative Proteins
6.7 Agricultural Biologicals

7 Global Biomanufacturing & Synthetic Biology Market, By Biological System

7.1 Bacteria
7.2 Yeast
7.3 Fungi
7.4 Mammalian Cells
7.5 Plant Cells
7.6 Cell-Free Systems
7.7 Engineered Microbial Consortia

8 Global Biomanufacturing & Synthetic Biology Market, By Application

8.1 Pharmaceutical Manufacturing
8.2 Industrial Enzyme Production
8.3 Food and Alternative Protein Production
8.4 Biofuel Production
8.5 Biochemical Manufacturing
8.6 Bioplastics Manufacturing
8.7 Agricultural Biotechnology
8.8 Environmental Biotechnology

9 Global Biomanufacturing & Synthetic Biology Market, By End User

9.1 Pharmaceutical and Biotechnology Companies
9.2 Contract Development and Manufacturing Organizations
9.3 Food and Beverage Companies
9.4 Chemical Companies
9.5 Industrial Biotechnology Companies
9.6 Agricultural Biotechnology Companies
9.7 Research Institutions
9.8 Consumer Products Companies

10 Global Biomanufacturing & Synthetic Biology Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiling

13.1 Novonesis A/S
13.2 DSM-Firmenich AG
13.3 Lonza Group AG
13.4 Thermo Fisher Scientific Inc.
13.5 Danaher Corporation
13.6 Merck KGaA
13.7 Sartorius AG
13.8 Evonik Industries AG
13.9 BASF SE
13.10 Agilent Technologies, Inc.
13.11 Bio-Rad Laboratories, Inc.
13.12 Ginkgo Bioworks Holdings, Inc.
13.13 Twist Bioscience Corporation
13.14 Codexis, Inc.
13.15 Illumina, Inc.
13.16 LanzaTech Global, Inc.
13.17 GenScript Biotech Corporation
13.18 Recursion Pharmaceuticals, Inc.

簡介目錄圖表

List of Tables

Table 1 Global Biomanufacturing & Synthetic Biology Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Biomanufacturing & Synthetic Biology Market Outlook, By Technology Platform (2023-2034) ($MN)
Table 3 Global Biomanufacturing & Synthetic Biology Market Outlook, By Precision Fermentation (2023-2034) ($MN)
Table 4 Global Biomanufacturing & Synthetic Biology Market Outlook, By Cell-Based Biomanufacturing (2023-2034) ($MN)
Table 5 Global Biomanufacturing & Synthetic Biology Market Outlook, By Cell-Free Biomanufacturing (2023-2034) ($MN)
Table 6 Global Biomanufacturing & Synthetic Biology Market Outlook, By Metabolic Engineering (2023-2034) ($MN)
Table 7 Global Biomanufacturing & Synthetic Biology Market Outlook, By Protein Engineering (2023-2034) ($MN)
Table 8 Global Biomanufacturing & Synthetic Biology Market Outlook, By Genome Engineering (2023-2034) ($MN)
Table 9 Global Biomanufacturing & Synthetic Biology Market Outlook, By AI-Driven Biological Design (2023-2034) ($MN)
Table 10 Global Biomanufacturing & Synthetic Biology Market Outlook, By Enzyme Engineering (2023-2034) ($MN)
Table 11 Global Biomanufacturing & Synthetic Biology Market Outlook, By Product Type (2023-2034) ($MN)
Table 12 Global Biomanufacturing & Synthetic Biology Market Outlook, By Biopharmaceuticals (2023-2034) ($MN)
Table 13 Global Biomanufacturing & Synthetic Biology Market Outlook, By Industrial Enzymes (2023-2034) ($MN)
Table 14 Global Biomanufacturing & Synthetic Biology Market Outlook, By Biofuels (2023-2034) ($MN)
Table 15 Global Biomanufacturing & Synthetic Biology Market Outlook, By Biochemicals (2023-2034) ($MN)
Table 16 Global Biomanufacturing & Synthetic Biology Market Outlook, By Bioplastics and Biomaterials (2023-2034) ($MN)
Table 17 Global Biomanufacturing & Synthetic Biology Market Outlook, By Alternative Proteins (2023-2034) ($MN)
Table 18 Global Biomanufacturing & Synthetic Biology Market Outlook, By Agricultural Biologicals (2023-2034) ($MN)
Table 19 Global Biomanufacturing & Synthetic Biology Market Outlook, By Biological System (2023-2034) ($MN)
Table 20 Global Biomanufacturing & Synthetic Biology Market Outlook, By Bacteria (2023-2034) ($MN)
Table 21 Global Biomanufacturing & Synthetic Biology Market Outlook, By Yeast (2023-2034) ($MN)
Table 22 Global Biomanufacturing & Synthetic Biology Market Outlook, By Fungi (2023-2034) ($MN)
Table 23 Global Biomanufacturing & Synthetic Biology Market Outlook, By Mammalian Cells (2023-2034) ($MN)
Table 24 Global Biomanufacturing & Synthetic Biology Market Outlook, By Plant Cells (2023-2034) ($MN)
Table 25 Global Biomanufacturing & Synthetic Biology Market Outlook, By Cell-Free Systems (2023-2034) ($MN)
Table 26 Global Biomanufacturing & Synthetic Biology Market Outlook, By Engineered Microbial Consortia (2023-2034) ($MN)
Table 27 Global Biomanufacturing & Synthetic Biology Market Outlook, By Application (2023-2034) ($MN)
Table 28 Global Biomanufacturing & Synthetic Biology Market Outlook, By Pharmaceutical Manufacturing (2023-2034) ($MN)
Table 29 Global Biomanufacturing & Synthetic Biology Market Outlook, By Industrial Enzyme Production (2023-2034) ($MN)
Table 30 Global Biomanufacturing & Synthetic Biology Market Outlook, By Food and Alternative Protein Production (2023-2034) ($MN)
Table 31 Global Biomanufacturing & Synthetic Biology Market Outlook, By Biofuel Production (2023-2034) ($MN)
Table 32 Global Biomanufacturing & Synthetic Biology Market Outlook, By Biochemical Manufacturing (2023-2034) ($MN)
Table 33 Global Biomanufacturing & Synthetic Biology Market Outlook, By Bioplastics Manufacturing (2023-2034) ($MN)
Table 34 Global Biomanufacturing & Synthetic Biology Market Outlook, By Agricultural Biotechnology (2023-2034) ($MN)
Table 35 Global Biomanufacturing & Synthetic Biology Market Outlook, By Environmental Biotechnology (2023-2034) ($MN)
Table 36 Global Biomanufacturing & Synthetic Biology Market Outlook, By End User (2023-2034) ($MN)
Table 37 Global Biomanufacturing & Synthetic Biology Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
Table 38 Global Biomanufacturing & Synthetic Biology Market Outlook, By Contract Development and Manufacturing Organizations (2023-2034) ($MN)
Table 39 Global Biomanufacturing & Synthetic Biology Market Outlook, By Food and Beverage Companies (2023-2034) ($MN)
Table 40 Global Biomanufacturing & Synthetic Biology Market Outlook, By Chemical Companies (2023-2034) ($MN)
Table 41 Global Biomanufacturing & Synthetic Biology Market Outlook, By Industrial Biotechnology Companies (2023-2034) ($MN)
Table 42 Global Biomanufacturing & Synthetic Biology Market Outlook, By Agricultural Biotechnology Companies (2023-2034) ($MN)
Table 43 Global Biomanufacturing & Synthetic Biology Market Outlook, By Research Institutions (2023-2034) ($MN)
Table 44 Global Biomanufacturing & Synthetic Biology Market Outlook, By Consumer Products Companies (2023-2034) ($MN)